These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 12568630)
41. [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis]. Chen Z; Li RL; Tu SH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):183-6. PubMed ID: 19382484 [No Abstract] [Full Text] [Related]
42. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Wang Y; Jia L; Wu CY Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267 [TBL] [Abstract][Full Text] [Related]
43. Triptolide: reflections on two decades of research and prospects for the future. Tong L; Zhao Q; Datan E; Lin GQ; Minn I; Pomper MG; Yu B; Romo D; He QL; Liu JO Nat Prod Rep; 2021 Apr; 38(4):843-860. PubMed ID: 33146205 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis. Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190 [TBL] [Abstract][Full Text] [Related]
45. [Structure modification of triptolide, a diterpenoid from Tripterygium wilfordii]. Yu DQ; Zhang DM; Wang HB; Liang XT Yao Xue Xue Bao; 1992; 27(11):830-6. PubMed ID: 1300027 [TBL] [Abstract][Full Text] [Related]
46. Treatment of Neurodegenerative Diseases with Bioactive Components of Li J; Hao J Am J Chin Med; 2019; 47(4):769-785. PubMed ID: 31091976 [No Abstract] [Full Text] [Related]
47. [Studies on diterpenoids from leaves of Tripterygium wilfordii]. Zhang CP; Lu XY; Ma PC; Chen Y; Zhang YG; Yan Z; Chen GF; Zheng QT; He CH; Yu DQ Yao Xue Xue Bao; 1993; 28(2):110-5. PubMed ID: 8328278 [TBL] [Abstract][Full Text] [Related]
48. [16-Hydroxytriptolide, a new active diterpene isolated from Tripterygium wilford II]. Ma PC; Lu XY; Yang JJ; Zheng QT Yao Xue Xue Bao; 1991; 26(10):759-63. PubMed ID: 1823717 [TBL] [Abstract][Full Text] [Related]
49. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. Kizelsztein P; Komarnytsky S; Raskin I J Neuroimmunol; 2009 Dec; 217(1-2):28-37. PubMed ID: 19796825 [TBL] [Abstract][Full Text] [Related]
50. Male antifertility compounds from Tripterygium wilfordii Hook f. Matlin SA; Belenguer A; Stacey VE; Qian SZ; Xu Y; Zhang JW; Sanders JK; Amor SR; Pearce CM Contraception; 1993 Apr; 47(4):387-400. PubMed ID: 8508668 [TBL] [Abstract][Full Text] [Related]
51. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Lin N; Liu C; Xiao C; Jia H; Imada K; Wu H; Ito A Biochem Pharmacol; 2007 Jan; 73(1):136-46. PubMed ID: 17097618 [TBL] [Abstract][Full Text] [Related]
52. [Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii]. Su D; Song Y; Li R Zhong Xi Yi Jie He Za Zhi; 1990 Mar; 10(3):144-6, 131. PubMed ID: 2379295 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats. Wang SR; Chen X; Ling S; Ni RZ; Guo H; Xu JW Biomed Pharmacother; 2019 Mar; 111():1467-1477. PubMed ID: 30841462 [TBL] [Abstract][Full Text] [Related]
54. [Advance in the anti-tumor mechanism of triptolide]. Luo Y; Shi C; Liao M Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(16):2024-6. PubMed ID: 19938536 [TBL] [Abstract][Full Text] [Related]
55. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide. Zhang Q; Li Y; Liu M; Duan J; Zhou X; Zhu H Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351251 [No Abstract] [Full Text] [Related]
56. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Zhao X; Liu Z; Ren Z; Wang H; Wang Z; Zhai J; Cao D; Lyu S; Li L; Lang R; He Q Eur J Pharmacol; 2020 Aug; 880():173225. PubMed ID: 32464191 [TBL] [Abstract][Full Text] [Related]
57. RNA polymerase - an important molecular target of triptolide in cancer cells. Pan J Cancer Lett; 2010 Jun; 292(2):149-52. PubMed ID: 20045594 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic applications and delivery systems for triptolide. Viegas JSR; Praça FG; Kravicz M; Bentley MVLB Drug Deliv Transl Res; 2020 Dec; 10(6):1584-1600. PubMed ID: 32789808 [TBL] [Abstract][Full Text] [Related]
59. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550 [TBL] [Abstract][Full Text] [Related]
60. A novel method to convert triptolide into tripchlorolide in Tripterygium wilfordii. Li B; Bai J; Yang G; Li Z; Wang L; Chen Y Phytochem Anal; 2006; 17(2):129-33. PubMed ID: 16634290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]